Medicare Enrolled
Dr. Fortune Alabi, MD
Pulmonary Disease · Kissimmee, FL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Alabi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Alabi?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Alabi
Dr. Fortune Alabi is a pulmonary disease specialist in Kissimmee, FL, with 21 years of NPI registration. Based on federal Medicare data, Dr. Alabi performed 5,616 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Alabi received a total of $559,545 from 72 pharmaceutical and/or device companies across 1974 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Alabi is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 21 years of NPI registration
▲ Top 5% volume in FL
$559,545 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 90480 | Clear | January 31, 2028 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary — 2023
Medicare Utilization ↗5,616
Medicare services
Top 5% in FL for pulmonary disease
Not available
Unique patients (not deduplicated)
$88
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Injection, benralizumab, 1 mg | 1,598 | $132 | $199 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
822 | $91 | $215 |
| Expiratory airflow and volume test A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume. |
556 | $20 | $73 |
| Lung volume test using sensors A test that measures the amount of air in the lungs using sensors. |
480 | $41 | $109 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
458 | $43 | $108 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
382 | $95 | $230 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
339 | $67 | $145 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
167 | $11 | $100 |
| CT scan of chest, without contrast A computed tomography scan of the chest area that uses X-rays to create detailed images without the use of contrast dye. |
134 | $107 | $290 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
110 | $64 | $145 |
| Chest X-ray, 2 views An X-ray imaging test of the chest that captures two different angles to visualize the lungs, heart, and chest wall. |
89 | $26 | $75 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
84 | $126 | $334 |
| New patient office visit, complex (60-74 min) | 76 | $163 | $414 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
69 | $136 | $388 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
43 | $174 | $568 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
38 | $64 | $65 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
37 | $25 | $26 |
| Sleep study in sleep lab (age 6+) An overnight test conducted in a sleep laboratory to monitor sleep patterns and bodily functions in patients aged 6 years or older. |
28 | $436 | $1,108 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
23 | $105 | $266 |
| Exercise-induced lung stress test A test performed to evaluate how the lungs function during physical exertion. It helps identify breathing difficulties or lung conditions that occur specifically when exercising. |
20 | $27 | $122 |
| Sleep study with continuous airway pressure, age 6+ A sleep study conducted in a sleep lab that monitors breathing and other body functions while administering continuous airway pressure. This test is performed on patients aged 6 years or older. |
19 | $452 | $1,223 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
19 | $137 | $288 |
| Sleep study with heart rate and breathing monitoring A sleep study that monitors heart rate, breathing patterns, and sleep duration. This test records physiological data while you sleep to assess your sleep quality and breathing function. |
13 | $115 | $518 |
| Lung cancer screening counseling visit A visit to discuss the need for lung cancer screening using a low-dose CT scan. This service is used to determine eligibility and facilitate shared decision making. |
12 | $28 | $60 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$559,545
Total received (2018-2024)
Avg $79,935/year across 7 years
Top 1% in FL for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
72
Companies
1,974
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$97,737
2023
$96,719
2022
$130,646
2021
$70,049
2020
$45,673
2019
$65,084
2018
$53,637
Payments by company (2024)
AstraZeneca Pharmaceuticals LP
$30,107
Boehringer Ingelheim Pharmaceuticals, Inc.
$17,350
GENZYME CORPORATION
$16,334
Mallinckrodt Hospital Products Inc.
$14,909
ANI Pharmaceuticals, Inc.
$7,364
Actelion Pharmaceuticals US, Inc.
$4,156
E.R. Squibb & Sons, L.L.C.
$2,397
Regeneron Healthcare Solutions, Inc.
$1,616
GlaxoSmithKline, LLC.
$591
United Therapeutics Corporation
$407
Insmed, Inc.
$340
JAZZ PHARMACEUTICALS INC.
$328
Pulmonx Corporation
$277
Amgen Inc.
$259
Grifols USA, LLC
$248
Axsome Therapeutics, Inc.
$156
Inspire Medical Systems, Inc.
$126
Takeda Pharmaceuticals U.S.A., Inc.
$115
Avadel CNS Pharmaceuticals, LLC
$115
Mylan Specialty L.P.
$106
Merck Sharp & Dohme LLC
$90
Bayer Healthcare Pharmaceuticals Inc.
$83
Electromed, Inc.
$69
Vifor Pharma, Inc.
$53
Sandoz Inc.
$51
Philips North America LLC
$23
Genentech USA, Inc.
$18
Tactile Systems Technology Inc
$18
Paratek Pharmaceuticals, Inc.
$18
HARMONY BIOSCIENCES LLC
$16
Top 3 companies account for 65.3% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$171,554
Boehringer Ingelheim Pharmaceuticals, Inc.
$117,015
Mallinckrodt Hospital Products Inc.
$60,593
E.R. Squibb & Sons, L.L.C.
$36,332
United Therapeutics Corporation
$25,128
GlaxoSmithKline, LLC.
$24,601
Regeneron Healthcare Solutions, Inc.
$20,389
GENZYME CORPORATION
$18,997
Actelion Pharmaceuticals US, Inc.
$15,467
Insmed, Inc.
$14,953
PFIZER INC.
$12,113
ANI Pharmaceuticals, Inc.
$10,338
Amgen Inc.
$8,335
Genentech USA, Inc.
$6,058
Philips Electronics North America Corporation
$1,967
ViiV Healthcare Company
$1,600
JAZZ PHARMACEUTICALS INC.
$1,470
Novartis Pharmaceuticals Corporation
$1,458
Grifols USA, LLC
$948
Edwards Lifesciences Corporation
$809
Harmony Biosciences LLC
$611
Bayer HealthCare Pharmaceuticals Inc.
$578
Jazz Pharmaceuticals Inc.
$494
Mylan Specialty L.P.
$473
Takeda Pharmaceuticals U.S.A., Inc.
$463
Sunovion Pharmaceuticals Inc.
$417
Pulmonx Corporation
$395
Paratek Pharmaceuticals, Inc.
$386
ZOLL Respicardia, Inc.
$312
CSL Behring
$295
SANOFI-AVENTIS U.S. LLC
$286
Merck Sharp & Dohme Corporation
$273
Ethicon Inc.
$270
Bayer Healthcare Pharmaceuticals Inc.
$269
Astute Medical, Inc.
$244
Electromed, Inc.
$227
Inspire Medical Systems, Inc.
$227
Vapotherm Inc
$226
Genentech, Inc.
$224
Allergan, Inc.
$211
Axsome Therapeutics, Inc.
$205
Merck Sharp & Dohme LLC
$190
bioMerieux
$189
HARMONY BIOSCIENCES LLC
$186
PORTOLA PHARMACEUTICALS, INC.
$155
Avadel CNS Pharmaceuticals, LLC
$149
La Jolla Pharmaceutical Company
$129
Gilead Sciences, Inc.
$128
IDORSIA PHARMACEUTICALS US INC
$125
Chiesi USA, Inc.
$118
Janssen Pharmaceuticals, Inc
$115
Teva Pharmaceuticals USA, Inc.
$101
Grifols Shared Services North America, Inc.
$80
Regeneron Pharmaceuticals, Inc.
$77
Sandoz Inc.
$68
Fisher & Paykel Healthcare Inc
$59
Boston Scientific Corporation
$54
Vifor Pharma, Inc.
$53
Mallinckrodt Enterprises LLC
$46
Allergan Inc.
$41
Itamar Medical Inc
$39
Shire North American Group Inc
$38
Inogen, Inc.
$35
Philips North America LLC
$23
Kite Pharma, Inc.
$22
Mallinckrodt LLC
$21
Tactile Systems Technology Inc
$18
Breas Medical, Inc.
$17
Hikma Pharmaceuticals USA
$17
Resmed Corp
$17
Phadia US Inc.
$16
ALK-Abello, Inc
$14
Top 3 companies account for 62.4% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · (AK6) Vest Therapy · ACTHAR · ADCIRCA · AIRSENSE · AIRSUPRA · ALAIR · ANDEXXA · ANORO · ANORO ELLIPTA · AREXVY · ASMANEX · AVYCAZ · Actemra · Adempas · AirDuo Digihaler · Arikayce · ArmonAir Digihaler · BEVYXXA · BREO · BREZTRI · BREZTRI AEROSPHERE · Betaseron · CHANTIX · CHARTIS CATHETER · CLEVIPREX · CUVITRU · ClearSight System · DIFICID · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · Dymista · ELIQUIS · EXALT Model D · Esbriet · FARXIGA · FASENRA · FEVIPIPRANT · FISHER & PAYKEL HEALTHCARE · Flexitouch Plus · GIAPREZA · GLASSIA · IMFINZI · INSPIRE · ImmunoCAP · InogenOne · LONHALA MAGNAIR · LUMRYZ · Monarch Platform · NEPHROCHECK TEST · NUCALA · NUZYRA · Nephrocheck · OFEV · OPSUMIT · OPSUMIT MACITENTAN · ORENITRAM · Obstructive Sleep Apnea Device or Hospital Respiratory Equipment · Odactra · PURIFIED CORTROPHIN GEL · Precision Flow · Prolastin-C · Prolastin-C Liquid · QUVIVIQ · REMODULIN · Respiratoriy Care Undiv · Ryaltris · SMARTVEST · SPIRIVA · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · Sunosi · TAGRISSO · TEFLARO · TEZSPIRE · TRELEGY ELLIPTA · TREPROSTINIL · TYVASO · Trilogy 100 · UPTRAVI · UTIBRON · Utibron · VAPOTHERM · Vivo 45 LS · WAKIX · WINREVAIR · Wakix · WatchPAT · WatchPATONE · Wellcentive Undiv · XARELTO · XOLAIR · XYREM · XYWAV · Xolair · Xyrem · YUPELRI · Yupelri · ZERBAXA · Zemaira · inCourage · remede System
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Pulmonary diseases in nearby ZIP areas
39
County median income
$68,711
Nearest hospital to ZIP centroid (approximate)
HCA FLORIDA POINCIANA HOSPITAL
4.1 mi
4.1 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Alabi is a clinical cardiology specialist, with above-average Medicare volume (top 5% in FL), with 21 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Alabi experienced with injection, benralizumab, 1 mg?
Based on Medicare claims data, Dr. Alabi performed 1,598 injection, benralizumab, 1 mg services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Alabi receive payments from pharmaceutical companies?
Yes. Dr. Alabi received a total of $559,545 from 72 companies across 1,974 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Alabi's costs compare to other pulmonary diseases in Kissimmee?
Dr. Alabi's average Medicare payment per service is $88. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Alabi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Kissimmee
Browse pulmonary diseases in Kissimmee ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in FL
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in FL
Which FL pulmonary diseases receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
By company
Mallinckrodt Hospital Products Inc. Payments to Doctors
See all physicians who received payments from Mallinckrodt Hospital Products Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology